Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of RABEP2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RABEP2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RABEP2 mRNA | affects expression | 16483693
|
C095105 |
bexarotene |
bexarotene results in increased expression of RABEP2 mRNA | increases expression | 16648578
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of RABEP2 mRNA | decreases expression | 15336504
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RABEP2 mRNA | affects cotreatment|increases expression | 17183730
|
C025299 |
polyphenols |
polyphenols results in decreased expression of RABEP2 mRNA | decreases expression | 16293270
|
C052785 |
rebamipide |
rebamipide results in increased expression of RABEP2 mRNA | increases expression | 15104358
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of RABEP2 mRNA | affects binding|decreases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RABEP2 mRNA | increases expression | 19465110
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of RABEP2 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.11 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.11 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.10 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.71 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.86 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.86 | 20603192 18940202 18396377 17157402 15238991 18316065 19460635 16609825 18558336 18775368 17507914 18177632 18985861 17688650 19232924 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.15 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.37 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.37 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
2.23 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.23 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
2.89 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.89 | 3084413 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.28 | 16247446 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 16120746 18670907 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.67 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.88 | 6135515 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.76 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.70 | 16293270 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.52 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.52 | 16575769 17688650 8888407 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.23 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.51 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.51 | 19420014 10915739 10774834 14725611 10663392 11739529 17522070 17906064 19164858 15968718 12540782 12705907 12594235 18071297 11421492 16081117 18713872 19085960 19923254 16177239 14550746 16781746 16227642 16109766 2444490 11529661 12958197 11461765 15619225 19416960 14986274 11743745 19370779 11287661 17562736 19739265 11834606 16485898 12392966 16393943 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
12.51 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.51 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.51 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.23 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 15322242 18230668 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.37 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.18 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.01 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.74 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.51 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.30 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.47 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.15 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.33 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.16 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 12621046 16120746 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 16959395 18606429 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.84 | 16870215 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.96 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.84 | 16612254 |
MESH:D007249 |
Inflammation |
|
polyphenols |
5.42 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.42 | 12878042 12200463 |
MESH:D007410 |
Intestinal Diseases |
|
rebamipide |
5.39 | 11686837 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.29 | 12587719 15629191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.12 | 16705839 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.28 | 19014921 11587558 19460945 12587719 19784758 16610002 16611625 12969438 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
4.28 | 16698588 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.07 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.07 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.53 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
2.58 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.58 | 19555203 11884234 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.36 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
3.51 | 15591091 19196722 19196723 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.31 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.20 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.24 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.10 | 18551238 7678174 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
5.05 | 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.23 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.01 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.59 | 16049721 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.53 | 16870215 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.27 | 11222880 11118676 11896295 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
10.27 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.81 | 12752131 11422049 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.36 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.32 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.32 | 3137016 17978042 14763951 15475178 1511512 11738929 11044598 16876388 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.83 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.83 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.81 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
rebamipide |
5.51 | 16184426 |
MESH:D013274 |
Stomach Neoplasms |
|
rebamipide |
3.21 | 15993841 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.52 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.50 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.76 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.34 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.86 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.56 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |